Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Identification for the Treatment of Complex Arrhythmias

NCT: NCT02565069 · COMPLETED

NCT IDNCT02565069
StatusCOMPLETED
Start Date2015-07-01
Completion2018-01-24
SponsorBiosense Webster, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary purpose of this trial is to demonstrate that the utilization of CartoFinder™ 4D Local Activation Time (LAT) Algorithm may help identify and improve the outcome for the treatment of complex arrhythmias.

Frequently Asked Questions

What is Identification for the Treatment of Complex Arrhythmias?

Identification for the Treatment of Complex Arrhythmias is a clinical trial registered under NCT02565069. Current status: COMPLETED.

What is the status of NCT02565069?

The current status of NCT02565069 (Identification for the Treatment of Complex Arrhythmias) is: COMPLETED.

When did Identification for the Treatment of Complex Arrhythmias start?

Identification for the Treatment of Complex Arrhythmias started on 2015-07-01.

Related Devices

K161701CARTO ENT SystemBiosense Webster K170600CARTO 3 EP Navigation System, Version 6.0 and AccessoriesBiosense Webster, Inc. K170997CARTO VIZIGO 8.5F Bi-Directional Guiding SheathBiosense Webster, Inc. K173977CARTO 3 EP Navigation System, Version 4.35 and Accessories with COHERENT MAP ModuleBiosense Webster, Inc. K173978CARTO 3 EP Navigation System, Version 5.2 and Accessories with CARTOFINDER ModuleBiosense Webster, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑